PA-21-261: PHS 2021-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required)
Closed
This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of National Institutes of Health notices from 2021.
National Institutes of Health offered grants to small businesses. Applications closed on April 5, 2022.
From the official notice on Grants.gov, last changed July 8, 2021. Checked November 7, 2026.
- Award amountsNot given on Grants.gov
- Cost sharingNot required
- Funding typeGrant
About this NIH notice
- Activity codeR41 / R42 / R44 / UT2
- Clinical trialsRequired
- Funded byNICHD, NCI, NIMH
- Median yearly award$384,184
- Typical project length3 years
- R41, Small Business Technology Transfer (STTR) Phase I. A small business and a research institution test the feasibility of a technology together. Other open R41 notices.
- R42, Small Business Technology Transfer (STTR) Phase II. Full development of an STTR project after Phase I. Other open R42 notices.
- R44, Small Business Innovation Research (SBIR) Phase II. Full research and development of an SBIR project after Phase I (or both phases at once, called Fast Track). Other open R44 notices.
Projects funded under PA-21-261 were run by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD, 4 projects), National Cancer Institute (NCI, 4 projects), National Institute of Mental Health (NIMH, 3 projects) and National Institute on Aging (NIA, 1 project), and 4 more. Contact the program officer at the institute that fits your project before you apply; the notice lists them.
Application due dates, page limits and budget limits are set in the notice. Read PA-21-261 in the NIH Guide.
Other notices with this title
Key dates
| Posted | July 8, 2021 |
|---|---|
| Deadline | April 5, 2022 |
| Archived by Grants.gov | May 11, 2022 |
Who can apply
This opportunity was open to small businesses.
- Small businesses
Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.
Is this a realistic fit?
- Most of the money in the 22 programs behind this notice (72% over five years) went to colleges and universities.
- No cost sharing or match is required.
What the grant funds
This Funding Opportunity Announcement (FOA), issued by the National Institutes of Health (NIH) invites eligible United States small businesses to submit Small Business Technology Transfer (STTR) grant applications. United States small businesses that have the research capabilities and technological expertise to contribute to the R and D mission(s) of the NIH awarding components identified in this FOA are encouraged to submit STTR grant applications in response to identified topics (see PHS 2021-2 SBIR/STTR Program Descriptions and Research Topics for NIH, CDC, and FDA). This Parent Funding Opportunity Announcement requires that at least 1 clinical trial be proposed. The proposed project must be related to the programmatic interests of one or more of the participating NIH Institutes and Centers (ICs) based on their scientific missions.
Funded under PA-21-261 so far
NIH funded 16 projects under PA-21-261 in fiscal 2022 to 2025, at 15 institutions. The median yearly award was $384,184.
| Project | Institution | Fiscal year | Award |
|---|---|---|---|
| Clinical effectiveness of a wearable hydration device | Tritonx Inc. | 2025 | $860,515 |
| An Efficacy Trial of Mobile Technology for Reducing and Preventing Adolescent Suicide | Oui Therapeutics, Inc | 2025 | $596,110 |
| An Interactive Education Program to Reduce High Risk Behavior in Adolescents | Klein Buendel, Inc. | 2024 | $938,856 |
| Translating an In-Person Brief, Bystander Bullying Intervention (STAC) to a Technology-Based - Phase II | Klein Buendel, Inc. | 2024 | $108,370 |
| Development and Randomized Clinical Trial of an App-based Intervention to Reduce Postpartum Depression in High-Risk Women | Fox Learning Systems, Inc. | 2024 | $250,783 |
| STING Activators as Therapy for Cancer | Stinginn, LLC | 2023 | $993,879 |
| Simulated Exposure Trainer (SET-VR): Implementing Targeted Experiential Training with a Virtual Patient | Virtually Better, Inc. | 2023 | $234,159 |
| Targeting OSCC cells with a lozenge to treat oral cancer | Sentrimed, Inc. | 2023 | $247,657 |
Who has won Aging Research grants before
From fiscal 2021 to 2025, Aging Research (93.866) awarded $19 billion across 11,026 grant awards, an average of $1.7 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| The Regents of the University of California, San Francisco | California | 337 | $575 million |
| The Trustees of Columbia University in the City of New York | New York | 242 | $574 million |
| University of Southern California | California | 203 | $572 million |
| The Washington University | Missouri | 210 | $556 million |
| Regents of the University of Michigan | Michigan | 232 | $538 million |
Who has won Cardiovascular Diseases Research grants before
From fiscal 2021 to 2025, Cardiovascular Diseases Research (93.837) awarded $15 billion across 11,798 grant awards, an average of $1.2 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| The Trustees of the University of Pennsylvania | Pennsylvania | 313 | $380 million |
| Brigham & Womens Hospital Inc | Massachusetts | 274 | $374 million |
| Regents of the University of Michigan | Michigan | 277 | $355 million |
| The Trustees of Columbia University in the City of New York | New York | 207 | $335 million |
| University of Pittsburgh - of the Commonwealth System of Higher Education | Pennsylvania | 295 | $320 million |
Who has won Biomedical Research and Research Training grants before
From fiscal 2021 to 2025, Biomedical Research and Research Training (93.859) awarded $15 billion across 11,631 grant awards, an average of $1.3 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| The Leland Stanford Junior University | California | 186 | $290 million |
| Regents of the University of Michigan | Michigan | 226 | $268 million |
| University of California, San Diego | California | 198 | $264 million |
| Yale Univ | Connecticut | 195 | $250 million |
| University of Wisconsin System | Wisconsin | 169 | $241 million |
Other programs behind this notice
- Mental Health Research Grants
- Drug Use and Addiction Research Programs
- Child Health and Human Development Extramural Research
- Cancer Treatment Research
- Cancer Biology Research
- Cancer Cause and Prevention Research
- National Center for Advancing Translational Sciences
- Cancer Detection and Diagnosis Research
- Alcohol Research Programs
- Human Genome Research
- Environmental Health
- Research Related to Deafness and Communication Disorders
- Minority Health and Health Disparities Research
- Discovery and Applied Research for Technological Innovations to Improve Human Health
- Cancer Control
- Nursing Research
- Research and Training in Complementary and Integrative Health
- Lung Diseases Research
- Translation and Implementation Science Research for Heart, Lung, Blood Diseases, and Sleep Disorders
Applying now
This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is PA-21-261 still open?
No. It closed on April 5, 2022.
Who can apply for PHS 2021-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required)?
National Institutes of Health accepted applications from small businesses. The notice adds further conditions, so read its eligibility section.
What is the deadline for PHS 2021-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required)?
Closed April 5, 2022. Applications are no longer accepted; the program's newer notices are on this page when there are any.
Who has been funded under PA-21-261?
NIH RePORTER lists 16 projects funded under PA-21-261 in fiscal 2022 to 2025, at 15 institutions. The most were at Klein Buendel, Inc., Tritonx Inc., Oui Therapeutics, Inc.
Who has won Environmental Health grants before?
The largest recipients over five fiscal years were Icahn School of Medicine at Mount Sinai, The Trustees of Columbia University in the City of New York, University of North Carolina at Chapel Hill. The program made 1,980 awards worth $2.1 billion in that time.
Similar open grants
- Small Business Transition Grant for New Entrepreneurs (Parent R43/R44 Clinical Trial Optional)
- Small Business Transition Grant for New Entrepreneurs (Parent R41/R42 Clinical Trial Optional)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
- Change of Recipient Organization (Type 7 Parent Clinical Trial Optional)
- Successor-in-Interest (Type 6 Parent Clinical Trial Optional)
- Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)